))
Episode 17: Using a rodent hepacivirus to uncover a role for iHALT during HCV infection
Manage episode 516075402 series 3601322
Content provided by CVIMP. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CVIMP or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.
18 episodes
Share
